This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Riverside Partners Invests In Stinger Medical Leader In Mobile Clinical Workstations

BOSTON and MURFREESBORO, Tenn., Jan. 4, 2013 /PRNewswire/ -- Riverside Partners, a Boston-based private equity firm, is pleased to announce that it has completed an investment in Stinger Medical ("Stinger"), a leading provider of mobile clinical workstations and medical technologies. Riverside Partners' investment was completed in partnership with the Stinger management team and the Founder of the business.

Headquartered in Murfreesboro, Tennessee, Stinger Medical provides mobile medical workstations and related technologies for the acute care market. Stinger has a long history of innovation in the medical cart industry. Its team is dedicated to creating products that streamline workflow processes, reduce errors, enhance the quality of patient care and help providers comply with meaningful use guidelines.  Stinger's proprietary Mobius Power solution and its fleet tracking technology, CAST, also enhance provider care to patients. 

"Given the rapidly evolving dynamics of today's healthcare ecosystem, Stinger was looking for an investment partner not only to help us grow, but also to help us navigate the increasingly complex healthcare IT market.  We believe that Riverside Partners' focus on technology investing as well as their deep expertise in healthcare makes them the perfect combination," said Gary Coonan, Founder and CEO of Stinger Medical.  "We are already beginning to benefit from the healthcare operating resources that come with our partnership with Riverside Partners." 

"Stinger Medical is clearly the innovation leader in the mobile clinical workstation industry and the company continues to develop advanced new technologies for this rapidly growing market. Stinger's products are pivotal in helping hospitals effectively deploy electronic health records and improve caregiver workflow and patient care," said Philip Borden, General Partner at Riverside Partners.  "And Stinger's strong commitment to R&D makes us even more excited about the future of technology integration with providers."   

About Stinger Medical Stinger Medical is the leading manufacturer of mobile solutions and medical technologies for the healthcare marketplace. Customers value Stinger Medical as a long-term partner that consistently delivers unmatched products and services. Leveraging more than a decade of healthcare experience, Stinger understands the unique needs of healthcare providers and is dedicated to creating products that streamline work flow processes, reduce errors, enhance quality of patient care, increase patient confidence, and put focus back on the patient.

For more information about Stinger Medical products and services, visit www.stingermedical.com.

About Riverside Partners Founded in 1989, Riverside Partners is a middle market private equity firm currently investing Riverside Partners Fund V, L.P.  The fund focuses on growth-oriented companies primarily in the healthcare and technology industries.  Riverside Partners is particularly experienced at partnering with founders, owners and management teams and it brings substantial domain expertise and operating experience to its portfolio companies.  Today, Riverside Partners manages $1 billion of equity capital and seeks to make investments in companies with revenues between $20 and $200 million and with $5-$25 million of EBITDA.  For more information, please visit http://www.riversidepartners.com.

SOURCE Riverside Partners

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,912.11 -70.48 -0.42%
S&P 500 1,969.95 -8.96 -0.45%
NASDAQ 4,442.6980 -2.2110 -0.05%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs